Jamjoom Pharmaceuticals Factory Co (SAU:4015) ROCE %: 38.52% (As of Mar. 2026)


SAU:4015 Jamjoom Pharmaceuticals Factory Co SAU:4015
73 GF Score
Price ﷼155.40
GF Value ﷼181.57
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Jamjoom Pharmaceuticals Factory Co ROCE %?

Jamjoom Pharmaceuticals Factory Co SAU:4015 -1.89% 73 ROCE % is 38.52% as of Mar. 2026. GuruFocus rates SAU:4015 with a GF Score™ of 73/100 and a GF Value™ of ﷼181.57 (Modestly Undervalued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Jamjoom Pharmaceuticals Factory Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 38.52%.

Jamjoom Pharmaceuticals Factory Co  (SAU:4015) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Jamjoom Pharmaceuticals Factory Co ROCE % Related Terms

Jamjoom Pharmaceuticals Factory Co ROCE % Historical Data

* Premium members only.

The historical data trend for Jamjoom Pharmaceuticals Factory Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jamjoom Pharmaceuticals Factory Co ROCE % Chart

Jamjoom Pharmaceuticals Factory Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial 14.76 14.48 22.93 25.15 29.10

Jamjoom Pharmaceuticals Factory Co Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.92 32.74 25.89 17.12 38.52
SAU:4015
73GF Score
Jamjoom Pharmaceuticals Factory Co SAU:4015
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jamjoom Pharmaceuticals Factory Co ROCE % Calculation

Jamjoom Pharmaceuticals Factory Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=493.292/( ( (1771.635 - 201.764) + (2045.56 - 224.55) )/ 2 )
=493.292/( (1569.871+1821.01)/ 2 )
=493.292/1695.4405
=29.10 %

Jamjoom Pharmaceuticals Factory Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=705.908/( ( (2045.56 - 224.55) + (2110.05 - 266.18) )/ 2 )
=705.908/( ( 1821.01 + 1843.87 )/ 2 )
=705.908/1832.44
=38.52 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 38.52% mean?
Jamjoom Pharmaceuticals Factory Co (SAU:4015) has a ROCE % of 38.52% as of Mar. 2026.
Is Jamjoom Pharmaceuticals Factory Co's ROCE % too high?
Jamjoom Pharmaceuticals Factory Co's current ROCE % is 38.52%. The Drug Manufacturers industry median ROCE % is 7.01. Jamjoom Pharmaceuticals Factory Co's value of 38.52% is 449.5% above this industry median. Overall, Jamjoom Pharmaceuticals Factory Co has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jamjoom Pharmaceuticals Factory Co's ROCE % compare to ZTS and UTHR?
Jamjoom Pharmaceuticals Factory Co's ROCE % of 38.52% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.01. Jamjoom Pharmaceuticals Factory Co's value of 38.52% is 449.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.01, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jamjoom Pharmaceuticals Factory Co's current ROCE % of 38.52% is 449.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jamjoom Pharmaceuticals Factory Co's current ROCE % is 38.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jamjoom Pharmaceuticals Factory Co stock overvalued right now?
Based on GuruFocus' analysis, Jamjoom Pharmaceuticals Factory Co (SAU:4015) is currently considered Modestly Undervalued. The stock's GF Value™ is ﷼181.57, compared to a current price of ﷼155.40 — trading 14.4% below its estimated fair value. The current ROCE % is 38.52% and 449.5% above the Drug Manufacturers industry median of 7.01. Jamjoom Pharmaceuticals Factory Co's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Jamjoom Pharmaceuticals Factory Co (SAU:4015), the current ROCE % is 38.52% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jamjoom Pharmaceuticals Factory Co (SAU:4015) Overvalued in 2026?

Based on GuruFocus' analysis, Jamjoom Pharmaceuticals Factory Co stock appears to be undervalued. The current stock price of ﷼155.40 is trading 14.4% below its estimated GF Value™ of ﷼181.57. GuruFocus considers Jamjoom Pharmaceuticals Factory Co to be Modestly Undervalued.

Key valuation signals for SAU:4015:

  • ROCE %: 38.52%
  • GF Value™: ﷼181.57 vs. price of ﷼155.40 (14.4% below fair value)
  • GF Score™: 73/100 with 2 warning signs
  • Industry Position: 449.5% above the Drug Manufacturers median

No single metric tells the full story. See the SAU:4015 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jamjoom Pharmaceuticals Factory Co Business Description

Address Corniche Road, P.O. Box No. 6267, 1234 Al Hamra District, Jeddah, SAU, 21442
Jamjoom Pharmaceuticals Factory Co is engaged in producing human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer and acidity, treatment of various skin infections, cancer diseases, eye drops and ointments and cosmeceuticals. Geographically the company has a presence in the Kingdom of Saudi Arabia, the Gulf, Iraq, Egypt, North Africa, and other export markets.
73GF Score

Get the complete analysis for SAU:4015

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼155.40
Price
﷼181.57
GF Value